New blood pressure genes announced

More than 100 new gene regions associated with high blood pressure have been identified, it was announced last night.

The findings could eventually help improve diagnosis and treatment, researchers say.

The research, which was led by Queen Mary University of London (QMUL) and Imperial College London, UK, suggests that doctors could target treatments for certain hypertension patients if they use genetic testing. They could also advise on lifestyle changes to reduce a risk of heart disease and stroke.

Writing in Nature Genetics, the research team reveal how they tested 9.8 million genetic variants from 420,000 UK Biobank participants and cross-referenced these with their blood pressure data.

Many of the new 107 gene regions found were expressed in high levels in blood vessels and cardiovascular tissue, and could be potential new drug targets for hypertension treatments, say the researchers.

They also developed a genetic ‘risk score’ by linking health and hospital data from UK Biobank participants with their blood pressure genetics, demonstrating that the score could be used to predict increased risk of stroke and coronary heart disease.

Professor Mark Caulfield, co-lead author of the study from QMUL, said if a genetic risk score could be measured in early life, a ‘personalised medicine’ approach might be feasible, which could offset a person’s high risk of stroke and heart disease.

“Finding 107 new genetic regions linked to blood pressure almost doubles the amount of genes we can evaluate to target for drug treatment,” he said. “These exciting genetic regions could provide the basis for new innovative preventative therapies and lifestyle changes for this major cause of heart disease and stroke.”

Professor Paul Elliott, co-lead author of the study and Chair in Epidemiology and Public Health Medicine at Imperial’s School of Public Health, added: “We cannot help our genetic makeup, but we can help our lifestyles and, in future, we may be able to alter our lifestyles while knowing whether we are at a genetic advantage or disadvantage.

“Doctors might eventually be able to determine a child’s genetic risk of diseases such as high blood pressure, diabetes, and maybe even cancer, so that they can live well enough to try to counteract the genetic input.”

Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk: The UK Biobank Cardio-metabolic Traits Consortium Blood Pressure Working Group. Nature Genetics 30 January 2017; doi: 10.1038/ng.3768.

, ,

Leave a Reply

Your email address will not be published. Required fields are marked *

Search

Categories

Monthly Posts

Our Clients

BSH
Practice Index